FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Ramaswamy Govindan

Research Profile

Disorders

Procedures

Concepts & Ideas

Chemicals & Drugs

Co-author Network

Publications

TOP 3
David H Gustafson; Robert Hawkins; Roberta Johnson; Kang Namkoong; Joan H Schiller; Anne M Traynor; Amy K Atwood; Abhik Bhattacharya; Mary K Buss; Toby C Campbell; Cindy L Carmack; Ming-Yuan Chih; Lori L Dubenske; Ramaswamy Govindan; James F Cleary
An eHealth system supporting palliative care for patients with non-small cell lung cancer: A randomized trial.
Suresh S Ramalingam; Nabil F Saba; Dong M Shin; Gabriel Sica; Janakiraman Subramanian; Shi-yong R Sun; Madhusmita Behera; Zhengjia Chen; Haian Fu; Anthony A Gal; Ramaswamy Govindan; R Donald Harvey; Carmen M Klass; Scott A Kono; Taofeek K Owonikoko; Fadlo R Khuri
Phase II study of docetaxel in combination with everolimus for second- or third-line therapy of advanced non-small-cell lung cancer.
Gregory P Kalemkerian; Marianna Koczywas; Billy W Loo; Robert E Merritt; Cesar A Moran; Harvey B Niell; Janis O'Malley; Jyoti D Patel; Neal Ready; Charles Rudin; Charles C Williams; Wallace Akerley; Paul Bogner; Hossein Borghaei; Laura Qm Chow; Robert J Downey; Leena Gandhi; Apar Kishor P Ganti; Ramaswamy Govindan; John C Grecula; Kristina Gregory; James A Hayman; Rebecca Suk Heist; Leora Horn; Thierry jahan; Miranda Hughes
Small cell lung cancer.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Ramaswamy Govindan (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: David H Gustafson; Robert Hawkins; Roberta Johnson; Kang Namkoong; Joan H Schiller; Anne M Traynor; Amy K Atwood; Abhik Bhattacharya; Mary K Buss; Toby C Campbell; Cindy L Carmack; Ming-Yuan Chih; Lori L Dubenske; Ramaswamy Govindan; James F Cleary
An eHealth system supporting palliative care for patients with non-small cell lung cancer: A randomized trial.
Cancer 2013;119(9):1744-51.
2013: Suresh S Ramalingam; Nabil F Saba; Dong M Shin; Gabriel Sica; Janakiraman Subramanian; Shi-yong R Sun; Madhusmita Behera; Zhengjia Chen; Haian Fu; Anthony A Gal; Ramaswamy Govindan; R Donald Harvey; Carmen M Klass; Scott A Kono; Taofeek K Owonikoko; Fadlo R Khuri
Phase II study of docetaxel in combination with everolimus for second- or third-line therapy of advanced non-small-cell lung cancer.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2013;8(3):369-72.
2013: Gregory P Kalemkerian; Marianna Koczywas; Billy W Loo; Robert E Merritt; Cesar A Moran; Harvey B Niell; Janis O'Malley; Jyoti D Patel; Neal Ready; Charles Rudin; Charles C Williams; Wallace Akerley; Paul Bogner; Hossein Borghaei; Laura Qm Chow; Robert J Downey; Leena Gandhi; Apar Kishor P Ganti; Ramaswamy Govindan; John C Grecula; Kristina Gregory; James A Hayman; Rebecca Suk Heist; Leora Horn; Thierry jahan; Miranda Hughes
Small cell lung cancer.
Journal of the National Comprehensive Cancer Network : JNCCN 2013;11(1):78-98.
2013: Melissa Rooney; Ramaswamy Govindan
The era of big trials is over.
The lancet oncology 2013;14(1):12-4.
2012: Ramaswamy Govindan
The articles in this supplement should be viewed more as meeting reports than as exhaustive and comprehensive review articles. Introduction.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2012;7(16 Suppl 5):S341.
2012: Siddhartha Devarakonda; Ramaswamy Govindan; Peter S Hammerman
Cancer gene sequencing: ethical challenges and promises.
The virtual mentor : VM 2012;14(11):868-72.
2012: Mark A Socinski; Ramaswamy Govindan; David Spigel
Clinical roundtable monograph: Recent advances in taxanes for the first-line treatment of advanced non-small cell lung cancer.
Clinical advances in hematology & oncology : H&O 2012;10(10 Suppl 18):1-16.
2012: Daniel Morgensztern; Janakiraman Subramanian; Kathryn Trinkaus; Saiama Waqar; Ramaswamy Govindan
Prognostic impact of malignant pleural effusion at presentation in patients with metastatic non-small-cell lung cancer.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2012;7(10):1485-9.
2012: Daniel Morgensztern; Janakiraman Subramanian; Kathryn Trinkaus; Saiama Waqar; Feng Gao; Ramaswamy Govindan
Prognostic significance of tumor size in patients with stage III non-small-cell lung cancer: a surveillance, epidemiology, and end results (SEER) survey from 1998 to 2003.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2012;7(10):1479-84.
2012: Ramaswamy Govindan; Malachi Griffith; Krishna L Kanchi; Christopher A Maher; Elaine R Mardis; Sandra McDonald; David Ornitz; Janakiraman Subramanian; Jason Walker; John Wallis; Mark Watson; Ron Bose; Ken Chen; Nathan D Dees; Li Ding; David J Dooling; Lucinda Fulton; Robert Fulton; Donghai Xiong; Ming You; Richard K Wilson
Genomic landscape of non-small cell lung cancer in smokers and never-smokers.
Cell 2012;150(6):1121-34.
2012: Giorgio V Scagliotti; Paulina Selaru; Janos Strausz; Aleksandra Szczesna; Michael Thomas; Sumitra Thongprasert; Lesley Tye; Joachim von Pawel; Rafal F Wierzbicki; Ke Zhang; Nina Karaseva; Maciej Krzakowski; Anatoly Makhson; Jose Elias Abrao Miziara; Zsolt S Papai; Elsa Dalmau Portulas; Martin Reck; Istvan Albert; Richard C Chao; Ramaswamy Govindan
Sunitinib plus erlotinib versus placebo plus erlotinib in patients with previously treated advanced non-small-cell lung cancer: a phase III trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2012;30(17):2070-8.
2012: Yan Lu; John Pfeifer; Ananth Sezhiyan; Liang Wang; Yian Wang; Weidong Wen; Ping Yang; Boone Goodgame; Ramaswamy Govindan; Xing Hua; Ya-fei Li; Peng-yuan Liu; Ming You
MicroRNA profiling and prediction of recurrence/relapse-free survival in stage I lung cancer.
Carcinogenesis 2012;33(5):1046-54.
2012: Janakiraman Subramanian; Saiama Waqar; Daniel Morgensztern; Ramaswamy Govindan
A roundup of articles published in recent months.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2012;7(3):626-8.
2012: Ramaswamy Govindan; Janakiraman Subramanian
Optimising therapy for EGFR-addicted NSCLC: just the start.
The lancet oncology 2012;13(3):216-7.
2012: Ezra E W Cohen; Leonardo Faoro; Feng Gao; Ramaswamy Govindan; Theodore Karrison; Mark F. Kozloff; Ravi Salgia; Janakiraman Subramanian; Livia Szeto; Everett E Vokes
Targeted and cytotoxic therapy in coordinated sequence (TACTICS): erlotinib, bevacizumab, and standard chemotherapy for non-small-cell lung cancer, a phase II trial.
Clinical lung cancer 2012;13(2):123-8.
2011: Janakiraman Subramanian; Saiama N Waqar; Ramaswamy Govindan
Targeted therapy in lung cancer: lessons learned from past experiences.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2011;6(11 Suppl 4):S1786-8.
2011: Ramaswamy Govindan
Summary of presentation from the targeted therapy in lung cancer meeting.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2011;6(11 Suppl 4):S1757.
2011: Gregory P Kalemkerian; Marianna Koczywas; Cesar A Moran; Harvey B Niell; Janis O'Malley; Jyoti D Patel; Neal Ready; Charles Rudin; Charles C Williams; Wallace Akerley; Paul Bogner; Hossein Borghaei; Laura Chow; Robert J Downey; Leena Gandhi; Apar Kishor P Ganti; Ramaswamy Govindan; John C Grecula; James A Hayman; Rebecca Suk Heist; Leora Horn; Thierry M Jahan
Small cell lung cancer.
Journal of the National Comprehensive Cancer Network : JNCCN 2011;9(10):1086-113.
2011: Ramaswamy Govindan
Hope without hype: EML4-ALK inhibition for treatment of lung cancer.
The lancet oncology 2011;12(11):983-4.
2011: Maria Q Baggstrom; Charles Erlichman; Ramaswamy Govindan; Elizabeth A Johnson; Marianna Koczywas; Michael J Millward; Sara C Murphy; Yingwei Qi; Charles Rudin; Athanassios Argiris
A phase II study of AT-101 (Gossypol) in chemotherapy-sensitive recurrent extensive-stage small cell lung cancer.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2011;6(10):1757-60.
2011: Ramaswamy Govindan; Lydia Hodgson; Robert A Kratzke; Thomas E Stinchcombe; Jeffrey Bogart; Timothy Brotherton; Jennifer Garst; Xiaofei Wang; Everett E Vokes
Randomized phase II study of pemetrexed, carboplatin, and thoracic radiation with or without cetuximab in patients with locally advanced unresectable non-small-cell lung cancer: Cancer and Leukemia Group B trial 30407.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011;29(23):3120-5.
2011: Thomas E Stinchcombe; Nirmal K Veeramachaneni; Jeffery Bogart; Robert Kratzke; Ramaswamy Govindan
Annual review of advances in non-small cell lung cancer research: a report for the year 2010.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2011;6(8):1443-50.
2011: Kimra Castleton; Thomas Fong; Feng Gao; Donna B Jeffe; Lisa Kehlenbrink; Andrea Wang-Gillam; Muhammad A Waqar; Ramaswamy Govindan
A survey of Internet utilization among patients with cancer.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2011;19(8):1183-90.
2011: Daniel Morgensztern; Ramaswamy Govindan
A roundup of recently published articles relevant to thoracic oncology.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2011;6(7):1295-7.
2011: Helen Barraclough; Lorinda Simms; Ramaswamy Govindan
Biostatistics primer: what a clinician ought to know: hazard ratios.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2011;6(6):978-82.
2011: Ramaswamy Govindan; Roy S Herbst; Michael D Kommor; Daniel Morgensztern; Kaku Saito; Paul Schaefer; Jitendra Gandhi; Christopher Zergebel; Joan Schiller
Phase II trial of S-1 as second-line therapy in patients with advanced non-small cell lung cancer.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2011;6(4):790-5.
2011: Martin J Edelman; Gregory Otterson; Joseph Leach; Thomas Malpass; Ravi Salgia; Dennie Jones; Tarak D Mody; Ramaswamy Govindan
Multicenter phase II trial of Motexafin gadolinium and pemetrexed for second-line treatment in patients with non-small cell lung cancer.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2011;6(4):786-9.
2011: Daniel Morgensztern; Nathan A Pennell; Janakiraman Subramanian; Ramaswamy Govindan
Summary of presentations from the 46th annual meeting of the American Society Of Clinical Oncology (2010): focus on developmental therapeutics related to lung cancer.
Clinical lung cancer 2011;12(2):94-9.
2011: Leigh Boehmer; Saiama Waqar; Sara Butler; Ananth Sezhiyan; Ramaswamy Govindan
Summary of presentations from the 46th annual meeting of the American Society of Clinical Oncology (2010): focus on supportive care issues related to lung cancer.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2011;6(3):645-9.
2011: Janakiraman Subramanian; Luis Corrales; Denis Soulieres; Daniel Morgensztern; Ramaswamy Govindan
Summary of presentations from the 46th Annual Meeting of the American Society of Clinical Oncology (2010) focus on tumor biology and biomarkers related to lung cancer.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2011;6(2):399-403.
2011: Thomas E Stinchcombe; Maria Q Baggstrom; Neeta Somaiah; George R Simon; Ramaswamy Govindan
Summary of presentations from the 46th Annual Meeting of the American Society of Clinical Oncology: focus on non-small cell lung cancer (2010).
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2011;6(1):227-32.
2011: Daniel Morgensztern; Ramaswamy Govindan
Best of the month: A round up of articles published in recent months.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2011;6(1):223-6.
2011: Maria Q Baggstrom; Saiama N Waqar; Ananth K Sezhiyan; Eve Gilstrap; Feng Gao; Daniel Morgensztern; Ramaswamy Govindan
Barriers to enrollment in non-small cell lung cancer therapeutic clinical trials.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2011;6(1):98-102.
2010: Shadia Jalal; Pablo Bedano; Lawrence Einhorn; Sumeet Bhatia; Rafat Ansari; Naftali Bechar; Karuna Koneru; Ramaswamy Govindan; Jingwei Wu; Menggang Yu; Bryan Schneider; Nasser Hanna
Paclitaxel plus bevacizumab in patients with chemosensitive relapsed small cell lung cancer: a safety, feasibility, and efficacy study from the Hoosier Oncology Group.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2010;5(12):2008-11.
2010: Maria Q Baggstrom; Ramaswamy Govindan
Radiotherapy.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2010;5(12 Suppl 6):S476-7.
2010: Daniel Morgensztern; Boone Goodgame; Ramaswamy Govindan
Vaccines and immunotherapy for non-small cell lung cancer.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2010;5(12 Suppl 6):S463-5.
2010: Ramaswamy Govindan
Summary of the proceedings from the 10th annual meeting of molecularly targeted therapy in non-small cell lung cancer.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2010;5(12 Suppl 6):S433.
2010: Leigh M Boehmer; Saiama N Waqar; Ramaswamy Govindan
Influenza vaccination in patients with cancer: an overview.
Oncology (Williston Park, N.Y.) 2010;24(12):1167-70.
2010: Eric Duncavage; Boone Goodgame; Ananth Sezhiyan; Ramaswamy Govindan; John Pfeifer
Use of microRNA expression levels to predict outcomes in resected stage I non-small cell lung cancer.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2010;5(11):1755-63.
2010: Nathan A Pennell; Ramaswamy Govindan
Time to move beyond clinical and pathologic classification of BAC.
Oncology (Williston Park, N.Y.) 2010;24(10):900-1.
2010: Janakiraman Subramanian; Daniel Morgensztern; Ramaswamy Govindan
Vascular endothelial growth factor receptor tyrosine kinase inhibitors in non-small-cell lung cancer.
Clinical lung cancer 2010;11(5):311-9.
2010: Andrea Wang-Gillam; Kristina Williams; Silvia Novello; Feng Gao; Giorgio V Scagliotti; Ramaswamy Govindan
Time to activate lung cancer clinical trials and patient enrollment: a representative comparison study between two academic centers across the atlantic.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(24):3803-7.
2010: Daniel Morgensztern; Ramaswamy Govindan
Best of the month: a roundup of articles published in recent months.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2010;5(8):1305-7.
2010: Janakiraman Subramanian; Anusha R Madadi; Monica Dandona; Kristina Williams; Daniel Morgensztern; Ramaswamy Govindan
Review of ongoing clinical trials in non-small cell lung cancer: a status report for 2009 from the ClinicalTrials.gov website.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2010;5(8):1116-9.
2010: Suresh S Ramalingam; Chandra P Belani; Philip C Mack; Everett E Vokes; Jeffrey Longmate; Ramaswamy Govindan; Marianna Koczywas; S Percy Ivy; David R Gandara
Phase II study of Cediranib (AZD 2171), an inhibitor of the vascular endothelial growth factor receptor, for second-line therapy of small cell lung cancer (National Cancer Institute #7097).
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2010;5(8):1279-84.
2010: Thomas E Stinchcombe; Ramaswamy Govindan
One more fallen star--ZODIAC and its implications.
The lancet oncology 2010;11(7):604-5.
2010: Thomas E Stinchcombe; Jeffrey Bogart; Dennis A Wigle; Ramaswamy Govindan
Annual review of advances in lung cancer clinical research: a report for the year 2009.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2010;5(7):935-9.
2010: Jeffrey D. Bradley; Jennifer Moughan; Mary V Graham; Roger W. Byhardt; Ramaswamy Govindan; Jack Fowler; James A Purdy; Jeff M Michalski; Elizabeth Gore; Hak Choy
A phase I/II radiation dose escalation study with concurrent chemotherapy for patients with inoperable stages I to III non-small-cell lung cancer: phase I results of RTOG 0117.
International journal of radiation oncology, biology, physics 2010;77(2):367-72.
2010: Jeffrey D. Bradley; Kyounghwa Bae; Mary V Graham; Roger W. Byhardt; Ramaswamy Govindan; Jack Fowler; James A Purdy; Jeff M Michalski; Elizabeth Gore; Hak Choy
Primary analysis of the phase II component of a phase I/II dose intensification study using three-dimensional conformal radiation therapy and concurrent chemotherapy for patients with inoperable non-small-cell lung cancer: RTOG 0117.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(14):2475-80.
2010: Ramaswamy Govindan
[A review of epidermal growth factor receptor/HER2 inhibitors in the treatment of patients with non-small-cell lung cancer].
Zhongguo fei ai za zhi = Chinese journal of lung cancer 2010;13(4):363-9.
2010: Ramaswamy Govindan
Lung cancer in never smokers: a new hot area of research.
The lancet oncology 2010;11(4):304-5.
2010: Vamsidhar Velcheti; Daniel Morgensztern; Ramaswamy Govindan
Management of patients with advanced non-small cell lung cancer: role of gefitinib.
Biologics : targets & therapy 2010;4():83-90.
2010: Janakiraman Subramanian; Ramaswamy Govindan
Lung cancer in 'Never-smokers': a unique entity.
Oncology (Williston Park, N.Y.) 2010;24(1):29-35.
2010: Ramaswamy Govindan
A review of epidermal growth factor receptor/HER2 inhibitors in the treatment of patients with non-small-cell lung cancer.
Clinical lung cancer 2010;11(1):8-12.
2010: Janakiraman Subramanian; Daniel Morgensztern; Boone Goodgame; Maria Q Baggstrom; Feng Gao; Jay F Piccirillo; Ramaswamy Govindan
Distinctive characteristics of non-small cell lung cancer (NSCLC) in the young: a surveillance, epidemiology, and end results (SEER) analysis.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2010;5(1):23-8.
2009: Boone Goodgame; Thomas E Stinchcombe; George Simon; Antoinette J Wozniak; Ramaswamy Govindan
Recent advances in lung cancer: summary of presentations from the 45th annual meeting of the American Society of Clinical Oncology (2009).
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2009;4(10):1293-300.
2009: Nithya Ramnath; Ramaswamy Govindan
Progress in the treatment of metastatic non-small-cell lung cancer: slow but steady!
Clinical lung cancer 2009;10(4):260-1.
2009: Jyoti D Patel; Philip D Bonomi; Mark A Socinski; Ramaswamy Govindan; Shengyan Hong; Coleman Obasaju; Eduardo J Pennella; Allicia C Girvan; Susan C Guba
Treatment rationale and study design for the pointbreak study: a randomized, open-label phase III study of pemetrexed/carboplatin/bevacizumab followed by maintenance pemetrexed/bevacizumab versus paclitaxel/carboplatin/bevacizumab followed by maintenance bevacizumab in patients with stage IIIB or IV nonsquamous non-small-cell lung cancer.
Clinical lung cancer 2009;10(4):252-6.
2009: Vamsidhar Velcheti; Yumi Kasai; Avinash K Viswanathan; Jon Ritter; Ramaswamy Govindan
Absence of mutations in the epidermal growth factor receptor (EGFR) kinase domain in patients with mesothelioma.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2009;4(4):559.
2009: Richard J Gralla; Martin J Edelman; Frank C Detterbeck; Thierry jahan; David M Loesch; Steven A Limentani; Ramaswamy Govindan; Guangbin Peng; Matthew J Monberg; Coleman K Obasaju; Mark A Socinski
Assessing quality of life following neoadjuvant therapy for early stage non-small cell lung cancer (NSCLC): results from a prospective analysis using the Lung Cancer Symptom Scale (LCSS).
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2009;17(3):307-13.
2009: Ramaswamy Govindan; Xiaofei Wang; Maria Q Baggstrom; Susan Burdette-Radoux; Lydia Hodgson; Everett E Vokes; Mark R Green
A phase II study of carboplatin, etoposide, and exisulind in patients with extensive small cell lung cancer: CALGB 30104.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2009;4(2):220-6.
2009: Daniel Morgensztern; Maria Q Baggstrom; Giancarlo Pillot; Benjamin Tan; Paula M Fracasso; Rama Suresh; Jonathan Wildi; Ramaswamy Govindan
A phase I study of pegylated liposomal doxorubicin and irinotecan in patients with solid tumors.
Chemotherapy 2009;55(6):441-5.
2009: Shadia Jalal; Rafat Ansari; Ramaswamy Govindan; Sumeet Bhatia; Daniel Bruetman; William Fisher; Gregory Masters; Angela White; Daniel Stover; Menggang Yu; Nasser Hanna
Pemetrexed in second line and beyond small cell lung cancer: a Hoosier Oncology Group phase II study.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2009;4(1):93-6.
2008: Nasser Hanna; Marcus Neubauer; Constantin T Yiannoutsos; Ronald C McGarry; James Arseneau; Rafat Ansari; Craig Reynolds; Ramaswamy Govindan; Anton Melnyk; William Fisher; Donald Richards; Daniel Bruetman; Thomas Anderson; Naveed Chowhan; Sreenivasa Nattam; Prasad Mantravadi; Cynthia Johnson; Tim Breen; Angela White; Lawrence Einhorn
Phase III study of cisplatin, etoposide, and concurrent chest radiation with or without consolidation docetaxel in patients with inoperable stage III non-small-cell lung cancer: the Hoosier Oncology Group and U.S. Oncology.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(35):5755-60.
2008: Janakiraman Subramanian; Ramaswamy Govindan
Small cell, big problem! Stem cells, root cause?
Clinical lung cancer 2008;9(5):252-3.
2008: Boone Goodgame; Nirmal Veeramachaneni; Alexander Patterson; Ramaswamy Govindan
Tracheo-esophageal fistula with bevacizumab after mediastinal radiation.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2008;3(9):1080-1.
2008: Ramaswamy Govindan; Jeffrey Bogart; Everett E Vokes
Locally advanced non-small cell lung cancer: the past, present, and future.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2008;3(8):917-28.
2008: Janakiraman Subramanian; Ramaswamy Govindan
Molecular genetics of lung cancer in people who have never smoked.
The lancet oncology 2008;9(7):676-82.
2008: Marco Trovo; Jeffrey Bradley; Issam El-Naqa; Ethan Foster; Bryan Meyers; Ramaswamy Govindan; Alexander Patterson
Esophageal carcinoma with celiac nodal metastases; curative or palliative?
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2008;3(7):751-5.
2008: Thomas J Lynch; George R Blumenschein; Jeffrey A Engelman; Igor Espinoza-Delgado; Ramaswamy Govindan; Jeff Hanke; Nasser H Hanna; John V Heymach; Fred R Hirsch; Pasi A Janne; Rogerio Lilenbaum; Ronald B Natale; Gregory J Riely; Lecia V Sequist; Geoffrey I Shapiro; Alice Shaw; Frances A Shepherd; Mark A Socinski; A Gregory Sorensen; Heather A Wakelee; Aaron Weitzman
Summary statement novel agents in the treatment of lung cancer: Fifth Cambridge Conference assessing opportunities for combination therapy.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2008;3(6 Suppl 2):S107-12.
2008: Lawrence H Einhorn; Philip Bonomi; Paul A Bunn; D Ross Camidge; David Paul Carbone; Hak Choy; Steven M Dubinett; David R Gandara; Laurie E Gaspar; Ramaswamy Govindan; David H Johnson; John D Minna; Giorgio Scagliotti; Howard J West; Roy S Herbst
Summary report 7th Annual Targeted Therapies of the Treatment of Lung Cancer.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2008;3(5):545-55.
2008: Daniel Morgensztern; Ramaswamy Govindan
Treatment of patients excluded from Eastern Cooperative Oncology Group 4599 and AVAiL studies: focus on brain metastasis and squamous histology.
Clinical lung cancer 2008;9 Suppl 2():S57-61.
2008: Daniel Morgensztern; Ramaswamy Govindan
Adjuvant chemotherapy for lung cancer: cisplatin doublets only?
Journal of the National Comprehensive Cancer Network : JNCCN 2008;6(3):277-84.
2008: David S Ettinger; Wallace Akerley; Gerold Bepler; Andrew C Chang; Richard T Cheney; Lucian R Chirieac; Thomas A D'Amico; Todd L Demmy; Steven Feigenberg; Robert A Figlin; Ramaswamy Govindan; Frederic W Grannis; Thierry jahan; Mohammad Jahanzeb; Anne Kessinger; Ritsuko Komaki; Mark G Kris; Corey J Langer; Quynh-Thu Le; Renato Martins; Gregory A Otterson; Jyoti D Patel; Francisco Robert; David J Sugarbaker; Douglas E Wood
Non-small cell lung cancer.
Journal of the National Comprehensive Cancer Network : JNCCN 2008;6(3):228-69.
2008: Thomas Fong; Daniel Morgensztern; Ramaswamy Govindan
EGFR inhibitors as first-line therapy in advanced non-small cell lung cancer.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2008;3(3):303-10.
2008: Boone Goodgame; Avinash Viswanathan; Ryan Miller; Feng Gao; Bryan Meyers; Richard J Battafarano; Alexander Patterson; Joel Cooper; Tracey J Guthrie; Jeffrey Bradley; Giancarlo Pillot; Ramaswamy Govindan
A clinical model to estimate recurrence risk in resected stage I non-small cell lung cancer.
American journal of clinical oncology 2008;31(1):22-8.
2008: Daniel Morgensztern; Boone Goodgame; Maria Q Baggstrom; Feng Gao; Ramaswamy Govindan
The effect of FDG-PET on the stage distribution of non-small cell lung cancer.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2008;3(2):135-9.
2008: Boone Goodgame; Giancarlo Pillot; Zhiyun Yang; Jabi Shriki; Bryan F Meyers; Jennifer Zoole; Feng Gao; Farrokh Dehdashti; Alexander Patterson; Barry A Siegel; Ramaswamy Govindan
Prognostic value of preoperative positron emission tomography in resected stage I non-small cell lung cancer.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2008;3(2):130-4.
2008: Mark A Socinski; Silvia Novello; Julie R Brahmer; Rafael Rosell; Jose M Sanchez; Chandra P Belani; Ramaswamy Govindan; James N Atkins; Heidi H Gillenwater; Cinta Pallares; Lesley Tye; Paulina Selaru; Richard C Chao; Giorgio V Scagliotti
Multicenter, phase II trial of sunitinib in previously treated, advanced non-small-cell lung cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(4):650-6.
2008: William L Read; Maria Q Baggstrom; Paula M Fracasso; Ramaswamy Govindan
A phase I study of bexarotene and rosiglitazone in patients with refractory cancers.
Chemotherapy 2008;54(3):236-41.
2008: Jonathan D Wildi; Maria Q Baggstrom; Rama Suresh; William Read; Paula M Fracasso; Ramaswamy Govindan
A phase I study of docetaxel and bexarotene.
Chemotherapy 2008;54(2):125-30.
2008: Frank C Detterbeck; Mark A Socinski; Richard J Gralla; Martin J Edelman; Thierry jahan; David M Loesch; Steven A Limentani; Ramaswamy Govindan; M B Zaman; Zhishen Ye; Matthew J Monberg; Coleman K Obasaju
Neoadjuvant chemotherapy with gemcitabine-containing regimens in patients with early-stage non-small cell lung cancer.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2008;3(1):37-45.
2008: Daniel Morgensztern; Michael C Perry; Ramaswamy Govindan
A phase II study of topotecan and docetaxel in patients with sensitive relapse small cell lung cancer.
Acta oncologica (Stockholm, Sweden) 2008;47(1):152-3.
2008: Wan-Teck Lim; Maria Q Baggstrom; William Read; Paula M Fracasso; Ramaswamy Govindan
A Phase I trial of weekly docetaxel and topotecan for solid tumors.
Acta oncologica (Stockholm, Sweden) 2008;47(2):311-5.
2007: A. William Blackstock; Ramaswamy Govindan
Definitive chemoradiation for the treatment of locally advanced non small-cell lung cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(26):4146-52.
2007: Vamsidhar Velcheti; Eve Gilstrap; Jeffrey Bradley; Ramaswamy Govindan
Radiation-induced myonecrosis presenting as a subcutaneous mass after combined modality therapy for non-small cell lung cancer.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2007;2(9):875-6.
2007: Janakiraman Subramanian; Vamsidhar Velcheti; Feng Gao; Ramaswamy Govindan
Presentation and stage-specific outcomes of lifelong never-smokers with non-small cell lung cancer (NSCLC).
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2007;2(9):827-30.
2007: Daniel Morgensztern; Ramaswamy Govindan
Is there a role for cetuximab in non small cell lung cancer?
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(15 Pt 2):s4602-5.
2007: Thomas J Lynch; Philip D Bonomi; Charles Butts; Angela M Davies; Jeffrey A Engelman; Ramaswamy Govindan; Roy S Herbst; John V Heymach; Bruce E Johnson; Renato G Martins; Roman Perez-Soler; Gregory J Riely; Alan B Sandler; Lecia V Sequist; Mark A Socinski; Kwok-Kin Wong; Carol S Hart
Novel agents in the treatment of lung cancer: Fourth Cambridge Conference.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(15 Pt 2):s4583-8.
2007: Vamsidhar Velcheti; Ramaswamy Govindan
Pneumocystis pneumonia in a patient with non-small cell lung cancer (NSCLC) treated with pemetrexed containing regimen.
Lung cancer (Amsterdam, Netherlands) 2007;57(2):240-2.
2007: Mike G Martin; Ramaswamy Govindan; Daniel Morgensztern
Second-line therapy for esophageal cancer.
Expert review of anticancer therapy 2007;7(6):871-6.
2007: Haris G Vikis; Mitsuo Sato; Michael James; Daolong Wang; Yian Wang; Min Wang; Dongmei Jia; Yan Liu; Joan E Bailey-Wilson; Christopher I Amos; Susan Pinney; Gloria M Petersen; Mariza de Andrade; Ping Yang; Jonathan S Wiest; Pamela R Fain; Ann Grossbart Schwartz; Adi F Gazdar; Colette Gaba; Henry Rothschild; Diptasri Mandal; Elena Kupert; Daniela Seminara; Avinash Viswanathan; Ramaswamy Govindan; John D Minna; Marshall W Anderson; Ming You
EGFR-T790M is a rare lung cancer susceptibility allele with enhanced kinase activity.
Cancer research 2007;67(10):4665-70.
2007: Janakiraman Subramanian; Vamsidhar Velcheti; Maria Q Baggstrom; Ramaswamy Govindan
Efficacy of vinorelbine in the second-line setting and beyond in non-small cell lung cancer.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2007;2(4):373.
2007: Wan-Teck Lim; W H Zhang; Ryan Miller; J W Watters; F Gao; A Viswanathan; Ramaswamy Govindan; howard mcleod
PTEN and phosphorylated AKT expression and prognosis in early- and late-stage non-small cell lung cancer.
Oncology reports 2007;17(4):853-7.
2007: Janakiraman Subramanian; Ramaswamy Govindan
Lung cancer in never smokers: a review.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(5):561-70.
2007: Vamsidhar Velcheti; Ramaswamy Govindan
Metastatic cancer involving bladder: a review.
The Canadian journal of urology 2007;14(1):3443-8.
2007: Paula M Fracasso; Howard Burris; Matthew A Arquette; Ramaswamy Govindan; Feng Gao; Lisa P Wright; Sherry A Goodner; F Anthony Greco; Suzanne F Jones; Noel Willcut; Catherine Chodkiewicz; Amit Pathak; Gregory M Springett; George R Simon; Daniel M Sullivan; Raphaël Marcelpoil; Shelley D Mayfield; David J Mauro; Christopher R Garrett
A phase 1 escalating single-dose and weekly fixed-dose study of cetuximab: pharmacokinetic and pharmacodynamic rationale for dosing.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(3):986-93.
2007: Vamsidhar Velcheti; Avinash K Viswanathan; Maria Q Baggstrom; Ramaswamy Govindan
Drug delivery and toxicity of adjuvant chemotherapy for non-small cell lung cancer (NSCLC): Washington University experience.
Acta oncologica (Stockholm, Sweden) 2007;46(6):869-70.
2007: Vamsidhar Velcheti; Ramaswamy Govindan
Hedgehog signaling pathway and lung cancer.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2007;2(1):7-10.
2007: Min Wang; Haris G Vikis; Yian Wang; Dongmei Jia; Daolong Wang; Laura J Bierut; Joan E Bailey-Wilson; Christopher I Amos; Susan Pinney; Gloria M Petersen; Mariza de Andrade; Ping Yang; Jonathan S Wiest; Pamela R Fain; Ann Grossbart Schwartz; Adi F Gazdar; John D Minna; Colette Gaba; Henry Rothschild; Diptasri Mandal; Elena Kupert; Daniela Seminara; Yan Liu; Avinash Viswanathan; Ramaswamy Govindan; Marshall W Anderson; Ming You
Identification of a novel tumor suppressor gene p34 on human chromosome 6q25.1.
Cancer research 2007;67(1):93-9.
2006: Yan Lu; William Lemon; Peng-Yuan Liu; Yijun Yi; Carl Morrison; Ping Yang; Zhifu Sun; Janos Szoke; William L Gerald; Mark Watson; Ramaswamy Govindan; Ming You
A gene expression signature predicts survival of patients with stage I non-small cell lung cancer.
PLoS medicine 2006;3(12):e467.
2006: Mark S Walker; Damon J Vidrine; Ellen R Gritz; Randy J Larsen; Yan Yan; Ramaswamy Govindan; Edwin Bailey Fisher
Smoking relapse during the first year after treatment for early-stage non-small-cell lung cancer.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2006;15(12):2370-7.
2006: Nasser Hanna; Rogerio Lilenbaum; Rafat Ansari; Thomas J Lynch; Ramaswamy Govindan; Pasi A Janne; Philip Bonomi
Phase II trial of cetuximab in patients with previously treated non-small-cell lung cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(33):5253-8.
2006: Giancarlo Pillot; William Read; Kristin L Hennenfent; Sharon Marsh; Feng Gao; Avinash Viswanathan; Kristopher Cummings; howard mcleod; Ramaswamy Govindan
A phase II study of irinotecan and carboplatin in advanced non-small cell lung cancer with pharmacogenomic analysis: final report.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2006;1(9):972-8.
2006: Michael P Fanucchi; Frank V Fossella; Robert Belt; Ronald Natale; Panos Fidias; David P Carbone; Ramaswamy Govindan; Luis E Raez; Francisco Robert; Maria Ribeiro; Wallace Akerley; Karen Kelly; Steven A Limentani; Jeffrey Crawford; Hans-Joachim Reimers; Rita Axelrod; Oscar Kashala; Shihong Sheng; Joan H Schiller
Randomized phase II study of bortezomib alone and bortezomib in combination with docetaxel in previously treated advanced non-small-cell lung cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(31):5025-33.
2006: Ramaswamy Govindan; John Crowley; Lee Schwartzberg; Peter Kennedy; Charles Williams; Bradley Ekstrand; Alan B Sandler; Dinah Jaunakais; Vanessa Bolejack; Richard Ghalie
Phase II trial of bexarotene capsules in patients with advanced non-small-cell lung cancer after failure of two or more previous therapies.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(30):4848-54.
2006: Ramaswamy Govindan; Nathan Page; Daniel Morgensztern; William Read; Ryan M Tierney; Anna Vlahiotis; Edward L Spitznagel; Jay F Piccirillo
Changing epidemiology of small-cell lung cancer in the United States over the last 30 years: analysis of the surveillance, epidemiologic, and end results database.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(28):4539-44.
2006: Vamsidhar Velcheti; Ramaswamy Govindan
Insulin-like growth factor and lung cancer.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2006;1(7):607-10.
2006: Ramaswamy Govindan; Ronald Natale; James L Wade Iii; Roy Herbst; Annetta Krebs; Richard Reiling; Thomas A Hensing; Antoinette J Wozniak; Chandra P Belani; Karen Kelly; Judith Ochs
Efficacy and safety of gefitinib in chemonaive patients with advanced non-small cell lung cancer treated in an Expanded Access Program.
Lung cancer (Amsterdam, Netherlands) 2006;53(3):331-7.
2006: Vamsidhar Velcheti; Avinash Viswanathan; Ramaswamy Govindan
The proportion of patients with metastatic non-small cell lung cancer potentially eligible for treatment with bevacizumab: a single institutional survey.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2006;1(5):501.
2006: K L Hennenfent; Ramaswamy Govindan
Novel formulations of taxanes: a review. Old wine in a new bottle?
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2006;17(5):735-49.
2006: Daniel Morgensztern; Ramaswamy Govindan
Clinical trials of antiangiogenic therapy in non-small cell lung cancer: focus on bevacizumab and ZD6474.
Expert review of anticancer therapy 2006;6(4):545-51.
2006: Giancarlo Pillot; Barry A Siegel; Ramaswamy Govindan
Prognostic value of fluorodeoxyglucose positron emission tomography in non-small cell lung cancer: a review.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2006;1(2):152-9.
2006: Janakiraman Subramanian; Giancarlo Pillot; Vamsidhar R Narra; Ramaswamy Govindan
Response to bortezomib (velcade) in a case of advanced bronchiolo-alveolar carcinoma (BAC). A case report.
Lung cancer (Amsterdam, Netherlands) 2006;51(2):257-9.
2006: Wan-Teck Lim; Ramaswamy Govindan
CASE 3. Benign pleural nodules in a patient with esophageal cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(3):525.
2006: Jeffrey A. Bogart; Ramaswamy Govindan
A randomized phase II study of radiation therapy, pemetrexed, and carboplatin with or without cetuximab in stage III non-small-cell lung cancer.
Clinical lung cancer 2006;7(4):285-7.
2006: Ramaswamy Govindan; Wan-Teck Lim; Matthew A Arquette; Sherry A Goodner; Carole L Fears; Joanne E Mortimer; Paula M Fracasso
A phase I trial of docetaxel and vinorelbine in patients with advanced non-small cell lung cancer.
Oncology reports 2006;15(1):123-7.
2005: Giancarlo Pillot; Ramaswamy Govindan
The role of docetaxel in N2 locally advanced non-small-cell lung cancer.
Clinical lung cancer 2005;7 Suppl 3():S87-92.
2005: Avinash Viswanathan; Giancarlo Pillot; Ramaswamy Govindan
Lack of response to erlotinib after progression on gefitinib in patients with advanced non-small cell lung cancer.
Lung cancer (Amsterdam, Netherlands) 2005;50(3):417-8.
2005: Richard J Battafarano; Richard Lee; G Alexander Patterson; Thoralf Sundt; Fernando Gutierrez; Farrokh Dehdashti; Jon Ritter; Ramaswamy Govindan; Jeffrey Bradley
Clinical-pathologic conference in general thoracic surgery: Cardiac lymphoma.
The Journal of thoracic and cardiovascular surgery 2005;130(3):870-4.
2005: Alexander S Krupnick; Daniel Kreisel; Andrew J Hope; Jeffrey D. Bradley; Ramaswamy Govindan; Bryan Meyers
Recent advances and future perspectives in the management of lung cancer.
Current problems in surgery 2005;42(8):540-610.
2005: Ramaswamy Govindan
Chemotherapy for metastatic NSCLC: current status and future direction.
Nature clinical practice. Oncology 2005;2(5):238-9.
2005: Gerald Clamon; James Herndon; Jeffrey Kern; Ramaswamy Govindan; Jennifer Garst; Dorothy Watson; Mark Green
Lack of trastuzumab activity in nonsmall cell lung carcinoma with overexpression of erb-B2: 39810: a phase II trial of Cancer and Leukemia Group B.
Cancer 2005;103(8):1670-5.
2005: Ramaswamy Govindan; Robert A Kratzke; James E Herndon; Gloria A Niehans; Robin Vollmer; Dorothy Watson; Mark R Green; Hedy L Kindler
Gefitinib in patients with malignant mesothelioma: a phase II study by the Cancer and Leukemia Group B.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(6):2300-4.
2004: Ramaswamy Govindan; howard mcleod; Prasad Mantravadi; Naomi S Fineberg; Paul R Helft; Kenneth Kesler; Nasser Hanna; Cindy Stoner; Rafat Ansari; Edward Fox
Cisplatin, fluorouracil, celecoxib, and RT in resectable esophageal cancer: preliminary results.
Oncology (Williston Park, N.Y.) 2004;18(14 Suppl 14):18-21.
2004: William Read; howard mcleod; Ramaswamy Govindan
Irinotecan and carboplatin in metastatic or recurrent NSCLC: an update.
Oncology (Williston Park, N.Y.) 2004;18(14 Suppl 14):15-7.
2004: Ramaswamy Govindan; David H Garfield
Treatment approaches in patients with advanced non-small cell lung cancer and poor performance status.
Seminars in oncology 2004;31(6 Suppl 11):27-31.
2004: Mark S Walker; Randy J Larsen; Denise M Zona; Ramaswamy Govindan; Edwin Bailey Fisher
Smoking urges and relapse among lung cancer patients: findings from a preliminary retrospective study.
Preventive medicine 2004;39(3):449-57.
2004: Jeffrey D. Bradley; Farrokh Dehdashti; Mark A Mintun; Ramaswamy Govindan; Kim Trinkaus; Barry A Siegel
Positron emission tomography in limited-stage small-cell lung cancer: a prospective study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(16):3248-54.
2004: William Read; Ryan M Tierney; Nathan C Page; Irene Costas; Ramaswamy Govindan; Edward L Spitznagel; Jay F Piccirillo
Differential prognostic impact of comorbidity.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(15):3099-103.
2004: Aruna Kommareddy; Margaret A Coplin; Feng Gao; Danelle Behnken; Edie Romvari; William Read; Ramaswamy Govindan
Single agent gefitinib as first line therapy in patients with advanced non-small cell lung cancer: Washington University experience.
Lung cancer (Amsterdam, Netherlands) 2004;45(2):221-5.
2004: William Read; Nathan C Page; Ryan M Tierney; Jay F Piccirillo; Ramaswamy Govindan
The epidemiology of bronchioloalveolar carcinoma over the past two decades: analysis of the SEER database.
Lung cancer (Amsterdam, Netherlands) 2004;45(2):137-42.
2004: Ramaswamy Govindan
Cetuximab in advanced non-small cell lung cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(12 Pt 2):4241s-4244s.
2004: Thomas J Lynch; Alex A. Adjei; Paul A Bunn; Raymond DuBois; David R Gandara; Giuseppe Giaccone; Ramaswamy Govindan; Roy S Herbst; Bruce E Johnson; Fadlo R Khuri; Roman Perez-Soler; Rafael Rosell; Eric K Rowinsky; Alan B Sandler; Giorgio V Scagliotti; Joan H Schiller; Geoffrey I Shapiro; Mark A Socinski; Carol S Hart
Novel agents in the treatment of lung cancer: conference summary statement.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(12 Pt 2):4199s-4204s.
2003: Ramaswamy Govindan; William Read; Joan Faust; Kathryn Trinkaus; Margaret K Ma; Sharyn D Baker; howard mcleod; Michael C Perry
Phase II study of docetaxel and irinotecan in metastatic or recurrent esophageal cancer: a preliminary report.
Oncology (Williston Park, N.Y.) 2003;17(9 Suppl 8):27-31.
2003: Ramaswamy Govindan; D Behnken; William Read; howard mcleod
Wound healing is not impaired by the epidermal growth factor receptor-tyrosine kinase inhibitor gefitinib.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2003;14(8):1330-1.
2003: Paula M Fracasso; Luis C Rodriguez; Thomas J Herzog; Carole L Fears; Sherry A Goodner; Ramaswamy Govindan; Joel Picus; Janet S Rader; Benjamin R Tan; Matthew A Arquette
Phase I dose and sequencing study of pegylated liposomal doxorubicin and docetaxel in patients with advanced malignancies.
Cancer 2003;98(3):610-7.
2003: Ramaswamy Govindan; William Read; Joan Faust; Howard Mc Leod
Irinotecan and carboplatin in metastatic or recurrent non-small-cell lung cancer.
Oncology (Williston Park, N.Y.) 2003;17(7 Suppl 7):27-9.
2003: Farrokh Dehdashti; Mark A Mintun; Jason S Lewis; Jeffrey Bradley; Ramaswamy Govindan; Richard Laforest; Michael J Welch; Barry A Siegel
In vivo assessment of tumor hypoxia in lung cancer with 60Cu-ATSM.
European journal of nuclear medicine and molecular imaging 2003;30(6):844-50.
2003: Robin T Vollmer; Ramaswamy Govindan; Stephen L Graziano; Gary Gamble; Jennifer Garst; Michael J Kelley; Robert H Christenson
Serum CYFRA 21-1 in advanced stage non-small cell lung cancer: an early measure of response.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(5):1728-33.
2003: Ramaswamy Govindan
Management of patients with non-small cell lung cancer and poor performance status.
Current treatment options in oncology 2003;4(1):55-9.
2002: Paula M Fracasso; Janet S Rader; Ramaswamy Govindan; T J Herzog; Matthew A Arquette; Alex Denes; D G Mutch; Joel Picus; Benjamin R Tan; Carole L Fears; Sherry A Goodner; S L Sun
Phase I study of rubitecan and gemcitabine in patients with advanced malignancies.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2002;13(11):1819-25.
2002: Matthew A Arquette; Todd Wasserman; Ramaswamy Govindan; David Garfield; Neil Senzer; Heidi Gillenwater; Mark A Socinski
Phase II evaluation of amifostine as an esophageal mucosal protectant in the treatment of limited-stage small cell lung cancer with chemotherapy and twice-daily radiation.
Seminars in radiation oncology 2002;12(1 Suppl 1):59-61.